SEARCH

Wind and wave energy will play a crucial part in decarbonising our world, slowing climate change and helping the UK government achieve its aim of net zero greenhouse gas emissions by 2050.

However, the transition from fossil fuels to renewable energy will require significant innovation. The increased competition this will cause means those companies leading the charge must ensure their inventions, ideas and products are fully protected against unwanted and unauthorised attention from their competitors.

Our patent attorneys will provide this protection, ensuring your IP rights continue to deliver your current objectives and support your long-term strategy.

New materials are addressing some of the main technical, economic and sustainability challenges facing the world today, creating huge commercial opportunities.

In an environment where the potential rewards are so high and the pace of innovation so fast, our team provides the deep technical expertise you need to stay ahead of the competition. With backgrounds in biomaterials, composites, conductive materials, graphene, 2D materials, metallurgy, polymers and semiconductors, we also bring a wide range of experience working in industry and a keen understanding of the commercial drivers impacting on your innovation.

While fossil fuels still provide most of the world’s electricity, traditional power generation is still the largest carbon emitter.

The world’s governments have pledged to drastically reduce local carbon emissions but, to do so, carbon capture, utilisation and storage technologies will need to be used extensively.

Our patent attorneys have worked on a range of projects involving capture, sequestration, utilisation, mobile carbon capture, direct air capture, oxy-combustion and bio energy carbon capture and storage technologies.

In the rapidly-changing MedTech space, our extensive IP expertise is employed collaboratively across life and physical science disciplines, devising robust IP strategies. Our specialist expertise spans: digital health/therapeutics (DTX); AI-based medicine; medical devices; medical imaging; non-imaging diagnostics; in vitro diagnostics; personalised care and assisted living; surgical and clinical equipment; research equipment and analytical equipment.